TCM
IMMU

Tekla Capital Management’s Immunomedics Inc IMMU Stock Holding History

Tekla Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-223,336
Closed -$19M – 214
2020
Q3 		$19M Sell
223,336
-273,767
-55% -$13.8M 0.71% 36
2020
Q2 		$17.6M Buy
497,103
+10,000
+2% +$292K 0.67% 35
2020
Q1 		$6.57M Hold
487,103
– – 0.3% 69
2019
Q4 		$10.3M Hold
487,103
– – 0.39% 57
2019
Q3 		$6.46M Buy
487,103
+97,790
+25% +$1.44M 0.28% 68
2019
Q2 		$5.4M Buy
389,313
+101,626
+35% +$1.53M 0.22% 87
2019
Q1 		$5.53M Sell
287,687
-143,840
-33% -$2.32M 0.22% 91
2018
Q4 		$6.16M Buy
431,527
+334,157
+343% +$6.63M 0.26% 78
2018
Q3 		$2.03M Buy
+97,370
New +$2.31M 0.07% 154
2015
Q2 		– Sell
-500,000
Closed -$1.92M – 136
2015
Q1 		$1.92M Buy
+500,000
New +$2.17M 0.08% 106

Tekla Capital Management's IMMU Position: Q4 2020 in Review

Tekla Capital Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 223,336 shares — an estimated $19M sold.

Tekla Capital Management first reported a position in IMMU in Q1 2015 and held it in 10 quarters. The position peaked at $19M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Tekla Capital Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Tekla Capital Management sold 223,336 Immunomedics Inc shares in Q4 2020, an estimated $19M.
  • Tekla Capital Management first reported a position in Immunomedics Inc in Q1 2015 and held it in 10 quarters.
  • Tekla Capital Management's Immunomedics Inc position peaked at $19M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Tekla Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.